Twist Bioscience (TWST) Income from Continuing Operations (2017 - 2026)
Twist Bioscience (TWST) posted quarterly Income from Continuing Operations of 44021000.0 for Q1 2026, down 11.86% YoY from 49945463.83 in Q1 2025, and down 44.3% sequentially from 30507000.0 in Q4 2025.
Twist Bioscience (TWST) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Twist Bioscience has disclosed Income from Continuing Operations across 10 years of filings, most recently posting 44021000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 11.86% year-over-year to 44021000.0; the TTM figure through Mar 2026 stood at 81266000.0 (up 57.49% YoY), while the FY2025 annual figure was 77651000.0, up 62.8% from the prior year.
- Income from Continuing Operations slipped to 44021000.0 in Q1 2026, from 30507000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for TWST reached as high as 20381000.0 in Q2 2025 and fell as low as 85580000.0 in Q2 2024.
- The 5-year median for Income from Continuing Operations is 44021000.0 (2026), against an average of 43405882.35.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 59.99% — and 2025, when it surged 123.82%.
- A 5-year view of Income from Continuing Operations shows it stood at 41824000.0 in 2022, then slipped by 2.83% to 43008000.0 in 2023, then gained by 26.53% to 31597000.0 in 2024, then advanced by 3.45% to 30507000.0 in 2025, then tumbled by 44.3% to 44021000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 44021000.0, 30507000.0, and 27119000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Twist Bioscience | 6.31 Bn | 6.14 Bn | 57.12 Mn | -44.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.02 Mn |
| Dec 31, 2025 | -30.51 Mn |
| Sep 30, 2025 | -27.12 Mn |
| Jun 30, 2025 | 20.38 Mn |
| Mar 31, 2025 | -39.35 Mn |
| Dec 31, 2024 | -31.60 Mn |
| Sep 30, 2024 | -34.65 Mn |
| Jun 30, 2024 | -85.58 Mn |
| Mar 31, 2024 | -45.49 Mn |
| Dec 31, 2023 | -43.01 Mn |
| Sep 30, 2023 | -46.24 Mn |
| Jun 30, 2023 | -57.40 Mn |
| Mar 31, 2023 | -59.18 Mn |
| Dec 31, 2022 | -41.82 Mn |
| Sep 30, 2022 | -51.13 Mn |
| Jun 30, 2022 | -60.52 Mn |
| Mar 31, 2022 | -60.67 Mn |
| Dec 31, 2021 | -45.56 Mn |
| Sep 30, 2021 | -41.27 Mn |
| Jun 30, 2021 | -40.04 Mn |